Endovascular brachytherapy

Endovascular brachytherapy has been successfully modified by scientists at Isotopen Technologie München AG (ITM), solving problems of radiation exposure to Rhenium-188. The researchers are now producing Rhenium-188 with previously unknown high specific activity in a new type of generator, Isotopen Technologie reports.

The new Wolfram applicator is said to significantly reduce radiation exposure...
The new Wolfram applicator is said to significantly reduce radiation exposure during Rhenium-PTA

The itm Rhenium-188 PTA solves the problems previously experienced with endovascular brachytherapy in the peripheral area. As there is a lack of suitable stents for the femoropopliteal area, restenosis following conventional PTA has been a big problem.

Rhenium-188 with very high specific beta-activity is administered via a radiation catheter immediately after dilatation of the stenosis. The radiation time is individually determined for the patient; it is generally between seven and ten minutes.

Using the itm Rhenium-188 PTA is simple, fast and safe, the firm reports. ‘A special applicator ensures that doctors are not exposed to any noteworthy levels of radiation despite the high activity levels used.’

Rhenium-188 beta rays have ideal characteristics within the vessels and radiation levels drop quickly. Radiation penetrates to a maximum level of about 3mm so that only the vascular walls are selectively radiated. The procedure is carried out on an angiography table and there is no need to transport the patient to the radiotherapy department, the company points out.

A centring unit is not needed in the vessel with the itm Rhenium-188 PTA. The catheter centres itself within the vessel when filled with the isotope, so the radiation dose is also homogenously distributed in vessels with irregular configuration, Isotopen Technologie says, adding: ‘Only 23% of long and complex femoropopliteal stenoses and vascular obliterations still remain open six months after PTA. With the itm Rhenium-PTA, the cumulative rate achieved after two years is around 46% of arteries treated.

08.03.2007

Read all latest stories

Related articles

Article •

Cardiac conundrum

France – Re-opening clogged arteries with metal stents has proved a life-saver for a majority of patients with coronary disease. Yet the high rates of complications and mortality for patients with…

Photo

Article •

Non invasive but effective

A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive…

Photo

Article •

Computerised model of the heart to develop new therapies

During a workshop organized by the European Science Foundation (ESF), researchers discussed further steps in developing computerised “in-silico” models of the heart that simulate the real heart…

Related products

Canon – Alphenix Core

Single Plane

Canon – Alphenix Core

Canon Medical Systems Europe B.V.
Ziehm – Vision R

Surgical II-C-Arms

Ziehm – Vision R

Ziehm Imaging GmbH
Ziehm – Vision RFD Hybrid Edition

Surgical Flat Panel C-Arms

Ziehm – Vision RFD Hybrid Edition

Ziehm Imaging GmbH
Agfa – DR 800 (Fluoroscopy)*

Flatpanel Fluoro

Agfa – DR 800 (Fluoroscopy)*

Agfa
Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosinaco anticoagulant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Canon – Alphenix 4D CT

Multi-Modality Suites

Canon – Alphenix 4D CT

Canon Medical Systems Europe B.V.
Subscribe to Newsletter